Larimar Therapeutics (LRMR) Interest Coverage Ratio Growth (5y) (2018 - 2025)
Larimar Therapeutics (LRMR) Interest Coverage Ratio Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -221.20% |
| Sep 30, 2025 | -84.48% |
| Jun 30, 2025 | -18.65% |
| Mar 31, 2025 | -25.82% |
| Dec 31, 2024 | 45.98% |
| Sep 30, 2024 | 34.36% |
| Jun 30, 2024 | -51.07% |
| Mar 31, 2024 | 43.56% |
| Dec 31, 2023 | 59.03% |
| Sep 30, 2023 | 46.31% |
| Jun 30, 2023 | 47.17% |
| Mar 31, 2023 | 35.91% |
| Sep 30, 2022 | 50.99% |
| Mar 31, 2022 | 62.05% |
| Dec 31, 2021 | 72.75% |
| Sep 30, 2021 | 45.02% |
| Jun 30, 2021 | 58.43% |
| Mar 31, 2021 | 59.28% |
| Dec 31, 2020 | 75.05% |
| Sep 30, 2020 | 54.37% |